Peptides aren’t broadly illegal, but most of the ones you’ve probably heard about online, like BPC-157, growth hormone peptides, and compounded semaglutide, can’t be legally sold for human use without FDA approval. The confusion comes from the fact that peptides occupy a gray zone: they’re not controlled substances like steroids or opioids, but they’re regulated as drugs, which means selling or buying them for personal use without a prescription violates federal law.
Peptides Are Drugs, Not Supplements
The core issue is classification. Under the Federal Food, Drug, and Cosmetic Act, any substance intended to treat, cure, or prevent disease is a drug, regardless of whether it’s synthetic or naturally derived. Peptides that affect hormones, healing, or metabolism clearly fall into that category. The FDA requires them to go through formal clinical trials and receive approval through a new drug application before they can be marketed to consumers.
This is different from dietary supplements like vitamins or protein powder, which face much lighter regulation. Some companies try to blur that line by marketing peptides as “supplements” or “wellness products,” but the FDA considers this illegal. Unapproved peptides promoted as treatments are classified as misbranded or adulterated under federal law, and the companies selling them risk warning letters, seizures, and injunctions.
The “Research Use Only” Loophole
If you’ve browsed peptide vendor websites, you’ve likely seen labels reading “for research use only” or “not for human consumption.” This designation allows companies to legally sell peptides for laboratory and experimental use. It’s a real regulatory category, but it’s being exploited on a massive scale. The sellers know their customers are injecting these compounds, not running experiments in a university lab.
Purchasing research-labeled peptides and using them on yourself violates FDA regulations. It can create legal consequences for both the seller and the buyer. In December 2024, the FDA sent warning letters to four peptide companies, including Xcel Peptides, Swisschems, Summit Research, and Prime Peptides, for introducing unapproved products into interstate commerce. The agency also targeted a company called Veronvy for selling oral GLP-1 products that falsely claimed FDA approval.
Why the FDA Restricts Specific Peptides
The FDA’s concern isn’t theoretical. Many peptides sold online have little or no safety data in humans. BPC-157 is a good example. It’s one of the most popular peptides in the fitness and biohacking world, but the FDA has stated plainly that it has “identified no, or only limited, safety-related information for the proposed routes of administration” and “lacks sufficient information to know whether the drug would cause harm when administered to humans.” The agency also flagged risks of immune reactions and problems with impurities in the manufacturing process.
BPC-157 was previously listed as a Category 2 substance, meaning the FDA considered it to pose significant safety risks when used in compounding. The nominators eventually withdrew it from the list, which didn’t make it legal to compound. It simply removed it from active consideration. Without appearing on an approved list, compounding pharmacies cannot legally use it as an ingredient.
Beyond individual compounds, research on biologically active peptides has documented a range of potential harms: damage to the intestinal wall, toxicity to red blood cells and immune cells, free radical production, and tissue damage through immune and enzymatic pathways. These aren’t just abstract lab findings. They underscore why regulators want clinical trials completed before people start injecting compounds they ordered online.
Compounded Semaglutide and Tirzepatide
The biggest legal battles in the peptide space right now involve compounded versions of GLP-1 drugs like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). During a period of drug shortages, compounding pharmacies were allowed to produce copies of these medications under enforcement discretion from the FDA. That window has now closed.
For state-licensed pharmacies compounding semaglutide injections, the enforcement discretion period has ended entirely. For outsourcing facilities, the FDA extended its grace period for semaglutide until May 22, 2025, but that deadline is firm. Tirzepatide faces the same restrictions: enforcement discretion for pharmacies compounding it has also ended.
Under current rules, a compounding pharmacy can only produce a copy of a commercially available drug if a prescriber documents that the compounded version contains a meaningful difference tailored to a specific patient. Even then, the FDA limits pharmacies to four or fewer prescriptions of that compounded product per calendar month before it considers the practice excessive. Outsourcing facilities face an even stricter standard: they can only use bulk drug substances that appear on an FDA-approved list or are on the drug shortage list. Neither semaglutide nor tirzepatide currently appears on either list.
Why Sports Organizations Ban Peptides
Peptides face a separate layer of prohibition in competitive sports. The World Anti-Doping Agency bans entire classes of peptide hormones and their releasing factors under its prohibited list. These include peptides that stimulate testosterone production in males (such as those mimicking luteinizing hormone or gonadotropin-releasing hormone), corticotrophin-related peptides that affect cortisol, and growth hormone along with all its analogues and fragments.
WADA also maintains a catch-all category called “Non-Approved Substances,” which covers compounds that haven’t been authorized by any regulatory body for human therapeutic use. BPC-157 is specifically named in this category. For athletes, using any of these peptides can result in an adverse analytical finding and a suspension, regardless of whether they obtained the peptide legally through a prescription or illegally through an online vendor.
What You Can and Can’t Legally Do
A handful of peptides are fully FDA-approved prescription medications. Insulin is a peptide. So are certain fertility drugs and growth hormone therapies. If your doctor prescribes one of these, you’re using a legal, regulated product with established safety data and quality controls.
What you can’t legally do is buy unapproved peptides from an online vendor, use research-labeled compounds on yourself, or obtain compounded versions of brand-name drugs outside the narrow conditions the FDA permits. The peptides themselves aren’t classified as controlled substances in most cases, so you’re unlikely to face criminal drug possession charges. But the sellers face serious federal enforcement, and the products you receive have no guaranteed purity, potency, or safety profile. The legal restrictions exist because these compounds haven’t cleared the same testing that approved drugs have, and the gap between “promising in a rat study” and “safe to inject into a human” is where real harm happens.